Feasibility of Capecitabine and Oxaliplatin Combination Chemotherapy Without Central Venous Access Device in Patients With Stage III Colorectal Cancer

XELOX chemotherapy without a CVAD is a feasible approach for treating patients with stage III CC in the adjuvant setting.